Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Efficacy Of Rhinophototherapy Compared To Intranasal Corticosteroids On The Nasal Mucosa

NCT: NCT05919316 · COMPLETED

NCT IDNCT05919316
StatusCOMPLETED
Start Date2023-07-04
Completion2024-11-10

Brief Summary

The aim of this study to compare the efficacy of Rhinophototherapy to Intranasal Corticosteroids on the the nasal mucosa of allergic rhinitis patients. The main question to answer is: Does intranasal phototherapy reduce inflammation in the tissue biopsy of the inferior turbinate mucosa compared to intranasal steroids? The hypothesis for this study is Intranasal phototherapy will reduce mucosal inflammation without mucosal damage and is comparable to intranasal steroids in allergic rhinitis patients

Frequently Asked Questions

What is The Efficacy Of Rhinophototherapy Compared To Intranasal Corticosteroids On The Nasal Mucosa?

The Efficacy Of Rhinophototherapy Compared To Intranasal Corticosteroids On The Nasal Mucosa is a clinical trial registered under NCT05919316. Current status: COMPLETED.

What is the status of NCT05919316?

The current status of NCT05919316 (The Efficacy Of Rhinophototherapy Compared To Intranasal Corticosteroids On The Nasal Mucosa) is: COMPLETED.

When did The Efficacy Of Rhinophototherapy Compared To Intranasal Corticosteroids On The Nasal Mucosa start?

The Efficacy Of Rhinophototherapy Compared To Intranasal Corticosteroids On The Nasal Mucosa started on 2023-07-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑